Journal article
Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
- Abstract:
-
Bisphosphonates are the first-line treatment for preventing fractures in osteoporosis patients. However, their use is contraindicated or to be used with caution in chronic kidney disease (CKD) patients, primarily because of a lack of information about their safety and effectiveness. We aimed to investigate the safety of oral bisphosphonates in patients with moderate to severe CKD, using primary-care electronic records from two cohorts, CPRD GOLD (1997–2016) and SIDIAP (2007–2015) in the UK an...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Journal of Bone and Mineral Research Journal website
- Volume:
- 36
- Issue:
- 5
- Pages:
- 820-832
- Publication date:
- 2021-02-08
- Acceptance date:
- 2020-12-11
- DOI:
- EISSN:
-
1523-4681
- ISSN:
-
0884-0431
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1149640
- Local pid:
- pubs:1149640
- Deposit date:
- 2020-12-14
Terms of use
- Copyright holder:
- American Society for Bone and Mineral Research (ASBMR)
- Copyright date:
- 2020
- Rights statement:
- © 2020 The Authors. Journal of Bone and Mineral Research published byWiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Check for updates
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record